A Phase I/II, Open-label, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of LBS-007 in Patients with Relapsed or Resistant Acute Leukemia

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT05756322

Study #:
STUDY00161473

Start Date:
Aug 27, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05756322

View Complete Trial Details & Eligibility at ClinicalTrials.gov